Drug development has always been a complex process. It involves improving the way drugs work and how they behave in the body. One exciting area of research is co-crystal technology. This method is eco-friendly, simple, and effective. It offers a new way to enhance the properties of drugs. A recent
Parkinson's disease is a tough condition to manage. It's not just about the shaking and movement issues. Many people with Parkinson's also struggle with depression. This is a big problem, and scientists are always looking for better ways to help. One interesting area of research is the kynurenine p
Gold nanoclusters combined with alpha-lipoic acid, or FANCs, are gaining attention in the medical field. These tiny particles have shown potential for creating new drugs. But here is the thing: while short-term tests on mice showed no immediate harm, the long-term effects remained a mystery. Re
Melanoma is a type of skin cancer that has seen huge improvements in treatment over the past few years. This has led to better outcomes and quality of life for patients. Doctors can now tell the difference between melanomas caused by long-term sun exposure and other types. This is thanks to advances
Imagine a tiny protein called MALT1. It's like a key player in a game of cancer survival. This protein is part of a group of enzymes called cysteine proteases. It's unique because it's the only paracaspase in humans. This means it has a special role in helping certain types of cancer cells stay aliv
Imagine a tiny molecule that can stop cancer in its tracks. That's what scientists are hoping for with thienopyrimidine. This special ring-shaped molecule is like a key that can unlock cancer cells' defenses. It does this by targeting something called protein kinases. These are like the bosses of ca
In recent years, the biopharmaceutical industry has seen a significant shift. Chinese companies are now at the forefront of developing innovative drugs. This trend has caught the attention of U. S. pharmaceutical giants, who are increasingly looking to China for promising new treatments. One notabl
Imagine if there were drugs that could tackle brain diseases in a whole new way. Brain diseases like Parkinson's and Alzheimer's are tough. They cause brain cells to die. Most drugs out there just treat the symptoms. They don't fix the root cause. This is where hybrid drugs come in. These are specia
At first glance, tau and CPEB3 might seem like an unlikely duo. Tau is a protein that can go rogue and form harmful clumps in Alzheimer's disease. On the other hand, CPEB3 is essential for long-term memory and forms functional clumps to do its job. So, what happens when these two memory-related prot
Xtalpi, a Hong Kong-listed company, is making waves in the tech world. It started with a bang in 2016. Wen Shuhao, the company's cofounder and chairman, and his team participated in a blind test. The challenge was to predict the 3D structure of molecules. These molecules show how effective a drug ca
